Skip to main content
SpringerLink
Log in

Azelastine in Pollen-Induced Allergic Rhinitis

A Pharmacodynamic Study of Onset of Action and Efficacy

  • Original Research Article
  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

The manifestation of rhinitic symptoms in 9 patients with grass pollen-induced rhinitis was studied during long term allergen exposure at physiological concentrations in the ‘Vienna Challenge Chamber’. Patients were pretreated with a single dose of azelastine (either 2.2mg orally or 0.28mg intranasally) or placebo. Nasal resistance was estimated by active anterior rhinomanometry every 15 minutes. Analysis of changes in nasal airways resistance demonstrated significant protection against allergen-induced nasal obstruction (p < 0.01) for azelastine administered by either route. The onset of action of treatment in relation to nasal obstruction was significantly more rapid for the nasal spray (135 minutes) than for the tablet (205 minutes) [p < 0.01] formulation. Similarly, the onset of effect derived from subjective assessment of symptom severity was markedly more rapid (60 minutes) after intranasal azelastine than after administration of the oral form (120 minutes). Tolerability of azelastine was good, with no side effects reported with either oral or intranasal therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Achterrath-Tuckermann U, Simmet T, Luck W, Szelenyi I, Peskar BA. Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance. Agents and Actions 24: 217–223, 1988

    Article  PubMed  CAS  Google Scholar 

  • Albazzaz MK, Patel KR. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma. Thorax 43: 306, 1988

    Article  PubMed  CAS  Google Scholar 

  • Bisgaard H, Olsson P, Bende M. Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans. Clinical Allergy 16: 289–297, 1986

    Article  PubMed  CAS  Google Scholar 

  • Casale TB. The interaction of azelastine with human lung histamine H1, beta and muscarinic receptor sites. Journal of Allergy and Clinical Immunology 83: 771–776, 1989

    Article  PubMed  CAS  Google Scholar 

  • Cauna N, Hinderer KH, Weniges RT. Sensory receptor organs of the human nasal respiratory mucosa. American Journal of Anatomy 124: 1323–1328, 1969

    Article  Google Scholar 

  • Chand N, Diamantis W, Sofia RD. Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents and Actions 19: 164–168, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Chand N, Nolan K, Diamantis W, Perhach Jr JL, Sofia RD. Inhibition of leukotriene (SRS-A-mediated acute lung anaphylaxis by azelastine in guinea pigs. Allergy 41: 473–478, 1986b

    Article  PubMed  CAS  Google Scholar 

  • Chand N, Pillar J, Diamantis W, Sofia RD. Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs. Agents and Actions 16: 318–322, 1985

    Article  PubMed  CAS  Google Scholar 

  • Corrado OJ, Gomez E, Baldwin DL, Clague JE, Davies RJ. The effect of nedocromil sodium on nasal provocation with allergen. Journal of Allergy and Clinical Immunology 80: 218–222, 1987

    Article  PubMed  CAS  Google Scholar 

  • Devillier P, Dessanges JF, Rakotosihanaka F, Ghaem A, Bousley HA, et al. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. European Respiratory Journal 1: 356–361, 1988

    PubMed  CAS  Google Scholar 

  • Dockhorn FJ, Bergner A, Connell JF, Falliers CJ, Grabiec SV, et al. Safety and efficacy of loratadine (Sch-29851), a new non-sedating antihistamine in seasonal allergic rhinitis. Annals of Allergy 58: 407–411, 1987

    PubMed  CAS  Google Scholar 

  • Holmber K, Bake B, Blychert LO, Pipkorn U. Effects of topical H1 and 2 receptor antagonists on symptoms and local vascular reactions induced by nasal allergen challenge. Allergy 44: 281–287, 1989

    Article  Google Scholar 

  • Horak F, Jäger S. The Vienna Challenge Chamber — a new method of allergy exposition tests. Wiener Klinische Wochenschrift 99: 509–510, 1987

    Google Scholar 

  • Howarth PH, Holgate ST. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hayfever. Thorax 39: 668–672, 1984

    Article  PubMed  CAS  Google Scholar 

  • Inoue Y. Basic studies on the antiallergic drug, 4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine). Nippon Ika Daigaku Zasshi 50: 371–378, 1983

    PubMed  CAS  Google Scholar 

  • Katayama S, Tsunoda H, Sakuma Y, Kai H, Tanaka I, et al. Effect of azelastine on the release and action of leukotriene C4 and D4. International Archives of Allergy and Applied Immunology 83: 284–289, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kemp GJP, Buckley CE, Gershwin ME, Buchman E, Cascio FL, et al. Multicentre, double-blind, placebo controlled trial of terfenadine in seasonal allergic rhinitis and conjunctivitis. Annals of Allergy 54: 502, 1985

    PubMed  CAS  Google Scholar 

  • Lenhard G, Gerhardt G. Azelastine, a new drug in the treatment of allergic rhinitis. New England and Regional Allergy Proceedings 9: 366, 1988

    Google Scholar 

  • Meltzer EO, Storms WW, Pierson WE, Cummins LH, Orgel HA, et al. Efficacy of azelastine in perennial allergic rhinitis: clinical and rhinomanometric evaluation. Journal of Allergy and Clinical Immunology 82: 447–455, 1988

    Article  PubMed  CAS  Google Scholar 

  • Miadonna A, Tedeschi A, Leggiere E, Lorini M, Folio G, et al. Behaviour and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. American Review of Respiratory Diseases 136: 357–362, 1987

    Article  CAS  Google Scholar 

  • Middleton E, Ferriola P, Drzewiecki G, Sofia RD. The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C. Agents and Actions 28: 8–15, 1989

    Article  Google Scholar 

  • Rajakulasingam K, Polosa R, Holgate ST, Church MK, Howarth PH. Comparative nasal responses to bradykinin, kallidin and des-arg9 bradykinin in non-rhinitic and atopic rhinitic subjects. Clinical and Experimental Allergy 20 (Suppl. 1): 57, 1990

    Google Scholar 

  • Spector SL, Perhach JL, Rohr AS, Rackelefsky GS, Katz RM, et al. Pharmacodynamic evaluation of azelastine in subjects with asthma. Journal of Allergy and Clinical Immunology 80: 75–80, 1987

    Article  PubMed  CAS  Google Scholar 

  • Walsh S, Robinson C, Howarth PH. The nasal effects of prostaglandin D2 in non-rhinitic and atopic rhinitic subjects. Abstract. Clinical and Experimental Allergy 20: 115, 1990

    Google Scholar 

  • Weiler JM, Donnelly A, Campbell BH, Connell JT, Diamond L, et al. Multicentre, double-blind, multiple dose, parallel-groups efficacy and safety trial of azelastine, chlorpheniramine, and placebo in the treatment of spring allergic rhinitis. Journal of Allergy and Clinical Immunology 32: 801–811, 1988

    Article  Google Scholar 

  • Zechel HJ, Brock N, Lenke D, Achterrath-Tuckermann U. Pharmacological and toxicological properties of azelastine, a novel antiallergic agent. Arzneimittel-Forschung/Drug Research 31: 1184–1193, 1981

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University ENT Clinic, Vienna, Austria

    E. Horak, S. Jäger, J. Toth, U. Berger & E. Nirnberger

Authors
  1. E. Horak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Toth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Nirnberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horak, E., Jäger, S., Toth, J. et al. Azelastine in Pollen-Induced Allergic Rhinitis. Drug Invest 7, 34–40 (1994). https://doi.org/10.1007/BF03257397

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257397

Keywords

Search

Navigation